Seven financial analysts recently offered their perspectives on Xylem (NYSE: XYL), setting an average price target of $159.71. The company reported $8.6 billion in revenue in 2024, demonstrating a strong net margin. However, Xylem lags behind its industry peers in key metrics such as revenue growth, Return on Equity (ROE), and Return on Assets (ROA). This analysis provides investors with updated insights into Xylem's market valuation and operational performance. The consensus target reflects a nuanced view, acknowledging strong margins while highlighting areas for growth improvement. Investors will likely monitor future reports for shifts in these performance indicators.
Get AI-powered deep analysis for every story with a paid subscription
Upgrade for Analysis